Alleavitch Doug 4
4 · NEVRO CORP · Filed Mar 7, 2019
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Alleavitch Doug
VP, Quality and Operations
Transactions
- Exercise/Conversion
Common Stock
2019-03-05$42.30/sh+1,031$43,611→ 27,016 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-03-05−1,031→ 15,469 totalExercise: $42.30Exp: 2028-11-26→ Common Stock (1,031 underlying)
Holdings
- 1,517(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 14,792 restricted stock units.
- [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from November 27, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.